Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

NEURO-ONCOLOGY

New glioblastoma heterogeneity atlas — a shared resource

Subjects

Tackling intertumoural and intratumoural heterogeneity is one of the most important challenges in the study and treatment of glioblastoma. A new anatomical transcriptional atlas of human glioblastoma associates established anatomical features with distinct molecular subclasses and provides open access to these well-annotated data for drug target validation and data-mining projects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: A multi-omic approach to the study of glioblastoma.

References

  1. Osswald, M. et al. Brain tumour cells interconnect to a functional and resistant network. Nature 528, 93–98 (2015).

    PubMed  CAS  Google Scholar 

  2. Puchalski, R. B. et al. An anatomic transcriptional atlas of human glioblastoma. Science 360, 660–663 (2018).

    Article  PubMed  CAS  Google Scholar 

  3. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008).

    Article  CAS  Google Scholar 

  4. Madhavan, S. et al. Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol. Cancer Res. 7, 157–167 (2009).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396–1401 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Kickingereder, P. et al. Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response. Clin. Cancer Res. 22, 5765–5771 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469–474 (2018).

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Wick, W. et al. MGMT testing — the challenges for biomarker-based glioma treatment. Nat. Rev. Neurol. 10, 372–385 (2014).

    Article  PubMed  CAS  Google Scholar 

  9. Mall, R. et al. RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes. Nucleic Acids Res. 46, e39 (2018).

    Article  PubMed  Google Scholar 

  10. Quail, D. F. & Joyce, J. A. The microenvironmental landscape of brain tumors. Cancer Cell 31, 326–341 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wolfgang Wick.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wick, W., Kessler, T. New glioblastoma heterogeneity atlas — a shared resource. Nat Rev Neurol 14, 453–454 (2018). https://doi.org/10.1038/s41582-018-0038-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-018-0038-3

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer